Incidence of Cancer in Adult patients with Congenital Heart Disease

Adults with congenital heart disease are exposed to cumulative radiation doses, from multiple catheterization procedures. Seeing as these patients are exposed since early age, the chance of stochastic effect due to radiation exposure are relatively higher than that of the elderly population.

Incidencia de cáncer en pacientes adultos con cardiopatías congénitas

It is clear the chance of incident cancer in adults with congenital heart disease is higher than that of the general population but, so far, there are no figures to estimate this association.


Read also: “Protective Shield RADPAD Reduces the Radiation Dose Received by Operators in the Cath Lab”.


The study population was obtained from the Quebec database. The study looked at cumulative doses during cardiac procedures for each patient until one-year prior cancer diagnosis.

 

The study included 24833 patients with congenital heart disease between 18 and 64 years from 1995 to 2009. After following up 250791 patients/year, researchers observed 602 cases of cancer at mean 55.4 years.

 

Cancer cumulative incidence at 64 years was estimated in 15.3% (CI 95%; 14.2-16.5).


Read also: “Radiation Exposure in Chronic Total Occlusions”.


Cancer patients had a bigger number of catheterization procedures than control patients. (1410 vs 921 every 1000 patients with congenital heart disease; p<0.0001).

 

Radiation was independently associated with cancer, both per procedure (OR: 1.08; CI 95%, 1.04-1.13) and per dose (OR: 1.10 per every 10 milliSieverts; CI 95%, 1.05 1.15).

 

Conclusion

This is the first large population-based study to look at the association between radiation exposure in cardiac procedures and the incidence of cancer in adults with congenital heart disease.

 

Editorial Comment

These findings should be confirmed by prospective studies to reinforce recommendations on radiation surveillance in a highly, early exposed population. This is vital if we are to standardize cancer prevention policies, currently non-existent. 

 

For now, physicians must ensure diagnostic and therapeutic procedures with the lowest possible radiation dose, without compromising quality.

 

Original title: Exposure to Low-Dose Ionizing Radiation from Cardiac Procedures and Malignancy Risk in Adults with Congenital Heart Disease Running.

Reference: Cohen et al. Circulation. 2017 Dec 21. [Epub ahead of print].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...